More specifically, after six weeks of anti‐TNF administration in IBD patients, serum prohepcidin, as well as IL‐6, C‐reactive protein, and ferritin concentrations decreased significantly, while serum iron, hemoglobin, and total transferrin levels increased (Cavallaro et al., 2017). This evidence concerns the gene IL6 and inflammatory bowel disease.